Takeda

Multinational enterprises actively participate in digital trade fairs and are optimistic about the development prospects of China’s digital economy_Shijiazhuang News Network

by
Multinational enterprises actively participate in digital trade fairs and are optimistic about the development prospects of China’s digital economy_Shijiazhuang News Network

The China Pavilion in the comprehensive pavilion of the 2nd Global Digital Trade Expo was taken on November 23.Photo by Xinhua News Agency reporter Liu Lingyi Xinhua News Agency, Hangzhou, November 27th. Title: Multinational companies actively participate in digital trade fairs and are optimistic about the development prospects of China’s digital economy. Xinhua News Agency … Read more

Takeda’s Strategic Focus on Gastroenterology Treatments and Rare Diseases Positions them for Growth

by
Takeda’s Strategic Focus on Gastroenterology Treatments and Rare Diseases Positions them for Growth

The Japanese pharmaceutical company Takeda has in its company strategy bet on the treatments of gastroenterology, and attend diseases rare such as hemophilia, oncology and vaccinesbecause it considers that this is where their innovation is required and with it they can grow. In interview with MILLENNIUMHernán Porcille, general director of the firm in Mexico, explained … Read more

Soon bring Japanese dengue vaccine to Vietnam

by
Soon bring Japanese dengue vaccine to Vietnam

(PLO)- Japan’s dengue vaccine is expected to be licensed for circulation in Vietnam in the near future. On September 28, the Pasteur Institute of Ho Chi Minh City organized a seminar “Orientations and solutions to improve the effectiveness of Dengue Hemorrhagic Fever (DHF) prevention in Vietnam”. A representative of this unit said that in the … Read more

Ben Kubik, CEO of Takeda Cono Sur, Discusses Advances in Dengue Vaccine and Takeda’s Approach to Innovation

by
Ben Kubik, CEO of Takeda Cono Sur, Discusses Advances in Dengue Vaccine and Takeda’s Approach to Innovation

Ben Kubik, CEO of Takeda Cono Sur, the Japanese pharmaceutical company that celebrated its 242nd anniversary, participated in the CEO Profile, an event organized by the newspaper El Cronista together with Apertura magazine. There, he anticipated the advances of the vaccine that the company created against dengue. “It is considered one of the 10 health … Read more